155 related articles for article (PubMed ID: 28632691)
1. 18F-FDG Uptake in Benign Fibrous Histiocytoma of Adrenal Gland: A Potential Pitfall.
Tan TH; Lai CNB
Clin Nucl Med; 2017 Aug; 42(8):622-623. PubMed ID: 28632691
[TBL] [Abstract][Full Text] [Related]
2. Increased FDG activity in a dermatofibroma in esophageal cancer patient.
Bingham BA; Hatef DA; Chevez-Barrios P; Blackmon SH; Kim MP
Clin Nucl Med; 2013 Mar; 38(3):e140-2. PubMed ID: 23357820
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/CT Imaging of Adrenal Liposarcoma.
Wang R; Fan Q; Tian R
Clin Nucl Med; 2020 Jul; 45(7):570-571. PubMed ID: 32453082
[TBL] [Abstract][Full Text] [Related]
4. Characterization of adrenocortical tumors by
Paladino NC; Guérin C; Lowery A; Attard A; Essamet W; Slotema E; Morange I; Castinetti F; Brue T; Loundou A; Taïeb D; Sebag F
Surg Oncol; 2018 Jun; 27(2):231-235. PubMed ID: 29937176
[TBL] [Abstract][Full Text] [Related]
5. False Suggestion of Malignant Transformation of Benign Bone Tumor by 18F-FDG PET/CT: A Potential Pitfall.
Chen YR; Kuo YC; Hsu CN; Hsieh TC; Kao CH
Clin Nucl Med; 2016 Oct; 41(10):774-5. PubMed ID: 27556801
[TBL] [Abstract][Full Text] [Related]
6. Markedly increased 18F-FDG uptake in a nonfunctioning adrenal adenoma mimicking malignancy.
Treglia G; Oragano L; Fadda G; De Gaetano AM; Raffaelli M; Rufini V
Clin Nucl Med; 2013 Aug; 38(8):e333-5. PubMed ID: 23486332
[TBL] [Abstract][Full Text] [Related]
7. A rare case of solitary fibrous tumor of the adrenal gland detected by (18)F-FDG PET/CT.
Treglia G; Oragano L; Fadda G; Raffaelli M; Lombardi CP; Castaldi P; Rufini V
Clin Nucl Med; 2014 May; 39(5):475-7. PubMed ID: 23640229
[TBL] [Abstract][Full Text] [Related]
8. Bilateral Adrenal Extremely Intense Metabolic Activity on 18F-FDG PET/CT in a Patient With Pheochromocytomas.
Chen X; Chen G; Fu Z; Li Q
Clin Nucl Med; 2019 Sep; 44(9):748-749. PubMed ID: 31107752
[TBL] [Abstract][Full Text] [Related]
9. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
[TBL] [Abstract][Full Text] [Related]
10. Benign Adrenal Nodule Mimicking Lymphoma Differentially Diagnosed by 18F-FDG and 18F-FGln PET/CT.
Xu X; Zhu H; Kung HF; Li N; Yang Z
Clin Nucl Med; 2021 Jun; 46(6):474-476. PubMed ID: 33661191
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions.
Ciftci E; Turgut B; Cakmakcilar A; Erturk SA
Nucl Med Commun; 2017 Sep; 38(9):788-794. PubMed ID: 28692494
[TBL] [Abstract][Full Text] [Related]
12. Bilateral adrenal gland metastasis from malignant fibrous histiocytoma: value of [F-18]FDG PET-CT for diagnosis of occult metastases.
Kobayashi E; Kawai A; Seki K; Tateishi U; Beppu Y
Ann Nucl Med; 2006 Dec; 20(10):695-8. PubMed ID: 17385309
[TBL] [Abstract][Full Text] [Related]
13. Current generation time-of-flight (18)F-FDG PET/CT provides higher SUVs for normal adrenal glands, while maintaining an accurate characterization of benign and malignant glands.
Koopman D; van Dalen JA; Stigt JA; Slump CH; Knollema S; Jager PL
Ann Nucl Med; 2016 Feb; 30(2):145-52. PubMed ID: 26644009
[TBL] [Abstract][Full Text] [Related]
14. Dermatofibroma mimicking malignancy on integrated F-18 fluorodeoxyglucose PET-CT.
Demir MK; Ozdemir H; Gençhallaç H; Altaner S; Kartal O
Diagn Interv Radiol; 2009 Mar; 15(1):61-3. PubMed ID: 19263377
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of unenhanced computed tomography and
Delivanis DA; Bancos I; Atwell TD; Schmit GD; Eiken PW; Natt N; Erickson D; Maraka S; Young WF; Nathan MA
Clin Endocrinol (Oxf); 2018 Jan; 88(1):30-36. PubMed ID: 28815667
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET/CT of a Rare Case of an Adenomatoid Tumor of the Adrenal Gland.
Dietz M; Neyrand S; Dhomps A; Decaussin-Petrucci M; Tordo J
Clin Nucl Med; 2020 Jul; 45(7):e331-e333. PubMed ID: 32404714
[TBL] [Abstract][Full Text] [Related]
17. Adrenal-to-liver SUV ratio is the best parameter for differentiation of adrenal metastases from adenomas using 18F-FDG PET/CT.
Watanabe H; Kanematsu M; Goshima S; Kondo H; Kawada H; Noda Y; Moriyama N
Ann Nucl Med; 2013 Aug; 27(7):648-53. PubMed ID: 23625579
[TBL] [Abstract][Full Text] [Related]
18. Performance of 18F-FDG PET/CT in the Characterization of Adrenal Masses in Noncancer Patients: A Prospective Study.
Guerin C; Pattou F; Brunaud L; Lifante JC; Mirallié E; Haissaguerre M; Huglo D; Olivier P; Houzard C; Ansquer C; Hindié E; Loundou A; Archange C; Tabarin A; Sebag F; Baumstarck K; Taïeb D
J Clin Endocrinol Metab; 2017 Jul; 102(7):2465-2472. PubMed ID: 28431167
[TBL] [Abstract][Full Text] [Related]
19. Clinical Value of 18F-FDG PET/CT in Detecting Adrenal Metastasis in Patients with Hepatocellular Carcinoma.
Lin Y; Jeng LB; Wang HY; Tsai SC; Lin WY; Kao CH
Technol Cancer Res Treat; 2015 Oct; 14(5):593-9. PubMed ID: 24945368
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG avid Sclerosing Angiomatoid Nodular Transformation (SANT) of spleen on PET-CT - a rare mimicker of metastasis.
Sharma P
Nucl Med Rev Cent East Eur; 2018; 21(1):53. PubMed ID: 29442349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
